Page last updated: 2024-08-16

ribavirin and Hypermelanosis

ribavirin has been researched along with Hypermelanosis in 16 studies

Research

Studies (16)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	6 (37.50)	29.6817
2010's	10 (62.50)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anty, R; Cardot-Leccia, N; Lacour, JP; Ortonne, JP; Passeron, T; Pop, S; Tran, A; Trucchi, R; Tsilika, K	1
Gómez, S; Marcoval, J; Martín, C; Notario, J	1
Güneş, P; Yaşar, B; Yaşar, Ş	1
Caturelli, E; Dell'Isola, S; Ghittoni, G; Ialungo, AM; Roselli, P; Starnini, G	1
Amorosa, VK; Kovarik, CL; Lin, J; Lott, JP	1
Itha, S; Radha Krishna, Y	1
Corrêa, ME; de Moraes, PC; Mautoni, MC; Noce, CW; Thomaz, LA	1
Chiu, MW; Farshidi, D	1
Goksugur, N; Karabay, O; Ogutlu, A	1
Chawla, YK; Dhiman, RK; Duseja, A; Ghosh, S	1
Bachmeyer, C; Pellen, JC	1
Debbiche, A; Fenniche, S; Kerkeni, N; Marrak, H; Mlika, RB; Mokhtar, I	1
González Díaz, P; López Peláez, MV; Téllez Molina, MJ; Vergas García, J	1
Akcan, Y; Kavak, A; Korkmaz, U	1
Bergholz, U; Ferenci, P; Formann, E; Gurguta, C; Kauer, C; Steindl-Munda, P	1
Arduino, RC; Barnett, BJ; Bull, L; Torres, HA	1

Reviews

1 review(s) available for ribavirin and Hypermelanosis

Article	Year
Tongue hyperpigmentation during PEG-interferon-alfa/ribavirin therapy in a non-Caucasian patient with chronic hepatitis C: a case report and review of the literature. International journal of dermatology, 2013, Volume: 52, Issue:5 Topics: Adult; Antiviral Agents; Black People; Drug Eruptions; Hepatitis C, Chronic; Humans; Hyperpigmentation; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Tongue	2013

Article

Year

Tongue hyperpigmentation during PEG-interferon-alfa/ribavirin therapy in a non-Caucasian patient with chronic hepatitis C: a case report and review of the literature.

International journal of dermatology, 2013, Volume: 52, Issue:5

Topics: Adult; Antiviral Agents; Black People; Drug Eruptions; Hepatitis C, Chronic; Humans; Hyperpigmentation; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Tongue

2013

Trials

1 trial(s) available for ribavirin and Hypermelanosis

Article	Year
Secondary hyperpigmentation during interferon alfa treatment for chronic hepatitis C virus infection. JAMA dermatology, 2013, Volume: 149, Issue:6 Topics: Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Hyperpigmentation; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Mucous Membrane; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Skin Pigmentation	2013

Article

Year

Secondary hyperpigmentation during interferon alfa treatment for chronic hepatitis C virus infection.

JAMA dermatology, 2013, Volume: 149, Issue:6

Topics: Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Hyperpigmentation; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Mucous Membrane; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Skin Pigmentation

2013

Other Studies

14 other study(ies) available for ribavirin and Hypermelanosis

Article	Year
Oral hyperpigmentation associated with interferon-alpha and ribavirin therapy for hepatitis C virus infection. Actas dermo-sifiliograficas, 2014, Volume: 105, Issue:2 Topics: Antiviral Agents; Female; Hepatitis C, Chronic; Humans; Hyperpigmentation; Interferon-alpha; Middle Aged; Mouth Diseases; Ribavirin	2014
Face skin hyperpigmentation during pegylated interferon and ribavirin therapy. The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology, 2015, Volume: 26, Issue:2 Topics: Antiviral Agents; Biopsy; Drug Combinations; Drug Therapy, Combination; Face; Hepatitis C, Chronic; Humans; Hyperpigmentation; Injections, Subcutaneous; Interferon-alpha; Male; Melanocytes; Middle Aged; Ribavirin; Skin; Treatment Outcome	2015
A surprising hyperpigmentation of the gums and tongue. Gut, 2008, Volume: 57, Issue:12 Topics: Adult; Antiviral Agents; Female; Gingival Diseases; Hepatitis C, Chronic; Humans; Hyperpigmentation; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Tongue Diseases	2008
Iatrogenic hyperpigmentation in chronically infected hepatitis C patients treated with pegylated interferon and ribavirin. Journal of the American Academy of Dermatology, 2009, Volume: 60, Issue:5 Topics: Antiviral Agents; Hepatitis C, Chronic; Humans; Hyperpigmentation; Iatrogenic Disease; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin	2009
What caused this lingual hyperpigmentation in a patient with chronic hepatitis C? Liver international : official journal of the International Association for the Study of the Liver, 2010, Volume: 30, Issue:3 Topics: Antiviral Agents; Hepatitis C, Chronic; Humans; Hyperpigmentation; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Tongue Diseases	2010
Tongue hyperpigmentation resulting from peginterferon alfa and ribavirin combination therapy: a case report. Journal of the American Dental Association (1939), 2009, Volume: 140, Issue:11 Topics: Aged; Antiviral Agents; Brazil; Diagnosis, Differential; Drug Combinations; Female; Hepatitis C; Humans; Hyperpigmentation; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Skin Pigmentation; Tongue Diseases	2009
Lingual hyperpigmentation from pegylated interferon and ribavirin treatment of hepatitis C. Journal of the American Academy of Dermatology, 2010, Volume: 62, Issue:1 Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C; Humans; Hyperpigmentation; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Tongue Diseases	2010
Tongue hyperpigmentation during interferon therapy. The Journal of dermatology, 2011, Volume: 38, Issue:3 Topics: Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Hyperpigmentation; Interferon alpha-2; Interferon-alpha; Middle Aged; Recombinant Proteins; Ribavirin; Tongue Diseases	2011
Tongue hyperpigmentation resulting from peginterferon alfa-2b and ribavirin treatment in a patient with chronic hepatitis C. Digestive diseases and sciences, 2012, Volume: 57, Issue:3 Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Hyperpigmentation; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Tongue; Tongue Diseases	2012
Tongue hyperpigmentation during hepatitis C treatment. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2012, Sep-18, Volume: 184, Issue:13 Topics: Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C; Humans; Hyperpigmentation; Interferon-alpha; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Tongue; Tongue Diseases	2012
[Lingual hyperpigmentation in a patient with chronic infection]. Enfermedades infecciosas y microbiologia clinica, 2013, Volume: 31, Issue:4 Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Hyperpigmentation; Interferons; Polyethylene Glycols; Pregnancy; Pregnancy Complications; Pregnancy Complications, Infectious; Ribavirin; Tongue Diseases	2013
Hair repigmentation in a hepatitis C patient treated with interferon and ribavirin. Dermatology (Basel, Switzerland), 2005, Volume: 211, Issue:2 Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Follow-Up Studies; Hair; Hepatitis C, Chronic; Humans; Hyperpigmentation; Interferons; Male; Middle Aged; Ribavirin; Risk Assessment; Severity of Illness Index	2005
Tongue and skin hyperpigmentation during PEG-interferon-alpha/ribavirin therapy in dark-skinned non-Caucasian patients with chronic hepatitis C. The American journal of gastroenterology, 2006, Volume: 101, Issue:1 Topics: Adult; Black People; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C, Chronic; Humans; Hyperpigmentation; Interferon alpha-2; Interferon-alpha; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Risk Assessment; Sampling Studies; Severity of Illness Index; Skin; Tongue	2006
Tongue hyperpigmentation in a caucasian patient coinfected with HIV and hepatitis C during peginterferon alfa-2b and ribavirin therapy. The American journal of gastroenterology, 2007, Volume: 102, Issue:6 Topics: Antiviral Agents; Female; Hepatitis C, Chronic; HIV Infections; Humans; Hyperpigmentation; Interferon alpha-2; Interferon-alpha; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Tongue Diseases; White People	2007